Home › All Companies › CLX › Quarterly Report

CLOROX CO /DE/ (CLX) — Quarterly Report

AI-Powered SEC Filing Analysis

← All CLX filings
Latest Quarterly Report Filed: 2026-04-30

Key Insights

  • The filing indicates Clorox completed divestiture activity during the period, including the sale of the Vitamins, Minerals and Supplements business (disposed in Q3 2025), and the Glad business was still held for sale as of March 31, 2026, suggesting portfolio restructuring to focus on core operations.
  • Multiple derivative instruments are in place (commodity contracts, foreign exchange forwards, interest rate contracts) indicating active hedging of commodity price volatility and foreign exchange exposure, which is critical given Clorox's exposure to raw material and international operations.
  • The company maintains multiple credit facilities including revolving credit agreements and delayed draw term loans as of March 31, 2026, providing financial flexibility for operations and strategic initiatives, though specific debt levels and liquidity position require review of balance sheet details.
Sentiment: Neutral Significance: 5/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Quarterly Report filings

Filed: 2026-02-03
  • The company reported a 5% decline in revenue for the second quarter of fiscal year 2026 compared to the prior year period, indicating potential headwinds in the business.
  • Gross margin decreased by 200 basis points year-over-year, suggesting pressure on profitability, which may impact the company's financial performance.
  • The company announced the divestiture of its Vitamins, Minerals, and Supplements business segment, which could signal a strategic shift in the company's focus and product portfolio.
Sentiment: Negative Significance: 6/10
View Original Filing →

Other reports for CLOROX CO /DE/

Insider Trading Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.